Tamoxifen's role in chemoprevention of breast cancer: An update
- 1 January 1995
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 59 (S22), 42-50
- https://doi.org/10.1002/jcb.240590807
Abstract
Tamoxifen is an oral antiestrogen first used in metastatic breast cancer in the early 1970s. Large clinical trials were initiated in the late 1970s and early 1980s to test the drug's role as adjuvant therapy in early stage breast cancer. Observations of marked decreases in the development of contralateral breast cancer among tamoxifen recipients suggested potential for the drug in chemoprevention of breast cancer, and a large clinical trial to test the efficacy of tamoxifen in prevention of invasive breast cancer among women at increased risk was implemented in the United States in 1992. This paper reviews the rational for the clinical studies of tamoxifen as a chemopreventive agent for breast cancer and summarizes new information that has contributed to our understanding of tamoxifen's actions at the molecular and clinical levels. Current knowledge about the drug's mechanism of estrogenic and antiestrogenic action and its beneficial effects on blood lipids and bone metabolism will be presented. Recent research findings about DNA adduct formation and hepatic lesions, tamoxifen-associated gynecologic conditions, and the occurrence of second primary cancers in other organ systems will also be discussed.Keywords
This publication has 41 references indexed in Scilit:
- Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogenCarcinogenesis: Integrative Cancer Research, 1994
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifenAmerican Journal of Obstetrics and Gynecology, 1994
- Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.Journal of Clinical Oncology, 1994
- Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450sCarcinogenesis: Integrative Cancer Research, 1994
- Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?Biochemical Journal, 1993
- Endometrial CarcinomasPublished by Springer Nature ,1992
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal WomenAnnals of Internal Medicine, 1991
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- TamoxifenDrugs, 1989